Table 4.
Diagnostic reliability: treated versus non-treated
| Average Between-Group difference [95% CI] | p | |
|---|---|---|
| InterChangeability_Dyn-AMRI | − 0.01 [− 0.03–0.02] | 0.529 |
| InterChangeability_HBP-AMRI | − 0.00 [− 0.03–0.02] | 0.819 |
| InterChangeability_NE-AMRI | − 0.01 [− 0.04–0.01] | 0.351 |
| InterChangeability_T2fatsat | − 0.01 [− 0.04–0.01] | 0.309 |
| InterChangeability_DWI | − 0.02 [− 0.05–0.01] | 0.263 |
| InterChangeability_HBp | − 0.01 [− 0.04–0.01] | 0.400 |
| Agreement_TOT_Dyn-AMRI | 0.03 [− 0.02–0.08] | 0.258 |
| Agreement_TOT_HBP-AMRI | 0.01 [− 0.05–0.08] | 0.662 |
| Agreement_TOT_NE-AMRI | 0.02 [− 0.04–0.09] | 0.482 |
| Agreement_Dyn-AMRI_HPB-AMRI | − 0.02 [− 0.08–0.04] | 0.597 |
| Agreement_Dyn-AMRI_NE-AMRI | − 0.02 [− 0.07–0.06] | 0.832 |
| Agreement_HPB-AMRI_NE-AMRI | 0.01 [− 0.06–0.08] | 0.796 |
| Agreement_TOT_DWI | 0.06 [− 0.01–0.13] | 0.087 |
| Agreement_TOT_T2 | 0.04 [− 0.02–0.10] | 0.159 |
| Agreement_TOT_HBp | − 0.01 [− 0.07–0.06] | 0.808 |
| Average difference_TOT_Dyn-AMRI | − 0.01 [− 0.06–0.03] | 0.548 |
| Average difference_TOT_HPB-AMRI | − 0.02 [− 0.07–0.03] | 0.380 |
| Average difference_TOT_NE-AMRI | − 0.04 [− 0.09–0.02] | 0.232 |
| Average difference_Dyn-AMRI_HPB-MRI | − 0.01 [− 0.07–0.05] | 0.751 |
| Average difference_Dyn-AMRI_NE-AMRI | − 0.02 [− 0.09—0.04] | 0.490 |
| Average difference_HBP-AMRI-NE-AMRI | − 0.01 [− 0.07–0.05] | 0.669 |
c-AMRI: complete abbreviated MRI; Dyn-AMRI: dynamic abbreviated MRI; HBP: hepatobiliary phase; HPB-AMRI: hepatobiliary phase abbreviated MRI; NE-AMRI: non-enhanced abbreviated MRI